Inhibitory effect of glycoprotein isolated from Opuntia ficus-indica var. saboten MAKINO on activities of allergy-mediators in compound 48/80-stimulated mast cells

Cellular Immunology

Volumn 264, Issue 1, 2010, Pages 78-85

  Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

Author keywords

Arachidonic acid; Cyclooxygenase 2 (COX 2); Extracellular signal regulated kinase (ERK 1 2); Histamine; Interleukin 4 (IL 4); Nuclear factor kappa B (NF B)

Indexed keywords

ARACHIDONIC ACID; BETA N ACETYLHEXOSAMINIDASE; CYCLOOXYGENASE 2; GLYCOPROTEIN; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OPUNTIA FICUS INDICA GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; HISTAMINE RELEASE; MALE; MAST CELL; MOUSE; NONHUMAN; OPUNTIA; OPUNTIA FICUS INDICA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ALLERGIC AGENTS; BETA-N-ACETYLHEXOSAMINIDASES; CELL LINE, TUMOR; HISTAMINE RELEASE; INTERLEUKIN-4; L-LACTATE DEHYDROGENASE; MALE; MAST CELLS; MICE; MICE, INBRED ICR; OPUNTIA; P-METHOXY-N-METHYLPHENETHYLAMINE; PLANT PROTEINS; RATS; SIGNAL TRANSDUCTION;

MUS; OPUNTIA FICUS-INDICA;

EID: 77954145232     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.05.001     Document Type: Article

References (41)

1. Wuthrich B. Epidemiology of the allergic diseases: are they really on the increase?. Int. Arch. Allergy Appl. Immunol. 1989, 90:3-10.
2. Stevens R.L., Austen K.F. Recent advances in the cellular, molecular biology of mast cells. Immunol. Today 1989, 10:381-386.
3. Church M.K., Levi-Schaffer F. The human mast cell. J. Allergy Clin. Immunol. 1997, 99:155-160.
4. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as ''tunable" effector and immunoregulatory cells: recent advances. Ann. Rev. Immunol. 2005, 23:749-786.
5. Miyajima I., Dombrowicz D., Martin T.R., Ravetch J.V., Kinet J.P., Galli S.J. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 1997, 99:901-914.
6. Galli S.J., Gordon J.R., Wershil B.K. Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 1991, 3:865-872.
7. Petersen L.J., Mosbech H., Skov P.S., Petersen, Mosbech H. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J. Allergy Clin. Immunol. 1996, 97:672-679.
8. Lagunoff D., Martin T.W., Read G. Agents that release histamine from mast cells. Annu. Rev. Pharmacol. Toxicol. 1983, 23:331-351.
9. Shin T.Y., Kim S.H., Suk K., Ha J.H., Kim I., Lee M.G., Jun C.D., Kim S.Y., Lim J.P., Eun J.S., Shin H.Y., Kim H.M. Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model. Toxicol. Appl. Pharmacol. 2005, 209:255-262.
10. Kim S.H., Lee S., Kim I.K., Kwon T.K., Moon J.Y., Park W.H., Shin T.Y. Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes. Food Chem. Toxicol. 2007, 45:2138-2144.
11. Kim S.H., Choi C.H., Kim S.Y., Eun J.S., Shin T.Y. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp. Biol. Med. 2005, 230:82-88.
12. Allansmith M.R., Baird R.S., Ross R.N., Barney N.P., Bloch K.J. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Acta Ophthalmol. Suppl. 1989, 192:145-153.
13. Schwartz L.B., Lewis R.A., Seldin D., Austen K.F. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 1981, 126:1290-1294.
14. Marquardt D.L., Wasserman S.I. Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. J. Immunol. 1983, 131:934-939.
15. Sheller J.R., Polosukhin V.V., Mitchell D., Cheng D.S., Peebles R.S., Blackwell T.S. Nuclear factor kappa B induction in airway epithelium increases lung inflammation in allergen-challenged mice. Exp. Lung Res. 2009, 35:883-895.
16. May M.J., Ghosh S. Signal transduction through NF-kappa B. Immunol. Today 1998, 19:80-88.
17. Arbabi S., Maier R.V. Mitogen-activated protein kinases. Crit. Care. Med. 2002, 30:S74-S79.
18. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta. 2005, 1754:253-262.
19. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 1996, 271:24313-24316.
20. Yamamoto H., Atsuchi N., Tanaka H., Ogawa W., Abe M., Takeshita A., Ueno H. Separate roles for H-Ras and Rac in signaling by transforming growth factor (TGF)-beta. H-Ras is essential for activation of MAP kinase, partially required for transcriptional activation by TGF-beta, but not required for signaling of growth suppression by TGF-beta. Eur. J. Biochem. 1999, 264(1):110-119.
21. Hinz B., Brune K. Cyclooxygenase-2-10 years later. J. Pharmacol. Exp. Ther. 2002, 300:367-375.
22. Hsu Y.W., Chi K.H., Huang W.C., Lin W.W. Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription factors. J. Immunol. 2001, 166:5388-5397.
23. Hansen T.E., Jorgensen J.B. Cloning and characterisation of p38 MAP kinase from Atlantic salmon A kinase important for regulating salmon TNF-2 and IL-1beta expression. Mol. Immunol. 2007, 44:3137-3146.
24. Han Y.N., Choo Y., Lee Y.C., Moon Y.I., Kim S.D., Choi J.W. Monoamine oxidase B inhibitors from the fruits of Opuntia ficus-indica var. saboten. Arch. Pharm. Res. 2001, 24:51-54.
25. Kim S.H., Baik S.Y., Jung K.H., Choi M.R., Yang B.H., Lee J.S., Oh D.Y., Choi I.G., Chung H., Chai Y.G. Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells. Neurosci. Lett. 2005, 374:53-57.
26. Tsang C.M., Wong C.K., Ip W.K., Lam C.W. Synergistic effect of SCF and TNF-alpha on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells. J. Leukoc. Biol. 2005, 78:239-247.
27. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol. 1987, 139:2605-2614.
28. Ennis M., Atkinson G., Pearce F.L. Inhibition of histamine release induced by compound 48/80 and peptide 401 in the presence and absence of calcium. Implications for the mode of action of anti-allergic compounds. Agents Actions 1980, 10:222-228.
29. Oh P.S., Lee S.J., Lim K.T. 90 kDa glycoprotein Isolated from Opuntia ficus-indica var. Saboten Makino has an antioxidative activity. Food Sci. Biotech. 2004, 13:781-789.
30. Shore P.A., Brukhalter A., Cohn V.H. A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 1959, 127:182-186.
31. Lim S., Choi J.W., Kim H.S., Kim Y.H., Yea K., Heo K., Kim J.H., Kim S.H., Song M., Kim J.I., Ryu S.H., Suh P.G. A myristoylated pseudosubstrate peptide of PKC-zeta induces degranulation in HMC-1 cells independently of PKC-zeta activity. Life Sci. 2008, 82:733-740.
32. Oh P.S., Lee S.J., Lim K.T. Glycoprotein isolated from Rhus verniciflua Stokes inhibits inflammation-related protein and nitric oxide production in LPS-stimulated RAW 264.7 cells. Biol. Pharm. Bull. 2007, 30:111-116.
33. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
34. Xing M., Firestein B.L., Shen G.H., Insel P.A. Dual role of protein kinase C in the regulation of cPLA2-mediated arachidonic acid release by P2U receptors in MDCK-D1 cells: involvement of MAP kinase-dependent and -independent pathways. J. Clin. Invest 1997, 99:805-814.
35. Incorvaia 35 C., Pravettoni C., Mauro M., Yacoub M.R., Tarantini F., Riario-Sforza G.G. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis. Monaldi Arch. Chest Dis. 2008, 69:78-80.
36. Senyshyn J., Baumgartner R.A., Beaven M.A. Quercetin sensitizes RBL-2H3 cells to polybasic mast cell secretagogues through increased expression of Gi GTP-binding proteins linked to a phospholipase C signaling pathway. J. Immunol. 1998, 160:5136-5144.
37. Chahdi A., Fraundorfer P.F., Beaven M.A. Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTP-binding proteins. J. Pharmacol. Exp. Ther. 2000, 292:122-130.
38. Mousli M., Bueb J.L., Bronner C., Rouot B., Landry Y. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol. Sci. 1990, 11:358-362.
39. Chahdi A., Daeffler L., Gies J.P., Landry Y. Drugs interacting with G protein alpha subunits: selectivity and perspectives. Fundam. Clin. Pharmacol. 1998, 12:121-132.
40. Wong C.K., Tsang C.M., Ip W.K., Lam C.W. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: Roles of ERK, p38 MAPK. And NF-kappaB, Allergy 2006, 61:289-297.
41. Min Y.D., Choi C.H., Bark H., Son H.Y., Park H.H., Lee S., Park J.W., Park E.K., Shin H.I., Kim S.H. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res. 2007, 56:210-215.